Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Offering GLP-1 Therapy for Weight Loss The time it takes to see results from GLP-1 depends on your body and your commitment to the treatment
Inflammatory Pathway Studies: Assessment of molecular processes involved in inflammatory signaling and cellular stress responses
FIGURE 9 4 Discussion MASLD is the leading chronic liver disease worldwide
Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026
US$ 28.49
US$ 27.80
US$ 22.87
US$ 22.01
US$ 21.20
US$ 22.45
